Drug Information

Drug General Information
Drug ID
D08QZD
Former ID
DNC001522
Drug Name
Y-40613
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535652]
Structure
Download
2D MOL

3D MOL
Formula
C30H24FN5O6
Canonical SMILES
COC(=O)C1=CC2=C(C=C1)OC(=N2)C(=O)C(CC3=CC=CC=C3)NC(=O)C<br />N4C(=NC=C(C4=O)N)C5=CC=C(C=C5)F
InChI
1S/C30H24FN5O6/c1-41-30(40)19-9-12-24-22(14-19)35-28(42-24)26(38)23(13-17-5-3-2-4-6-17)34-25(37)16-36-27(33-15-21(32)29(36)39)18-7-10-20(31)11-8-18/h2-12,14-15,23H,13,16,32H2,1H3,(H,34,37)
InChIKey
YGRSMPVCBHOYMS-UHFFFAOYSA-N
PubChem Compound ID
9829503
PubChem Substance ID
14788687, 24130991, 44927626, 77903041, 103192711, 103995792, 129793318, 134340686, 137275625, 232801488
Target and Pathway
Target(s) Chymase Target Info Inhibitor [535652]
KEGG Pathway Renin-angiotensin system
Reactome Activation of Matrix Metalloproteinases
Metabolism of Angiotensinogen to Angiotensins
WikiPathways ACE Inhibitor Pathway
Metabolism of Angiotensinogen to Angiotensins
References
Ref 535652Therapeutic potential of a specific chymase inhibitor in atopic dermatitis. Jpn J Pharmacol. 2002 Nov;90(3):214-7.
Ref 535652Therapeutic potential of a specific chymase inhibitor in atopic dermatitis. Jpn J Pharmacol. 2002 Nov;90(3):214-7.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.